University of California San Francisco
Give to UCSF
UCSF is the lead institution on a California-based, six-university consortium that was awarded $12 million by the NIDCR to develop strategies for treating craniofacial and dental defects.
UCSF researchers have discovered a way to switch off the widely used CRISPR-Cas9 gene-editing system using newly identified anti-CRISPR proteins that are produced by bacterial viruses.
UCSF researchers have taken a major step toward understanding the function of the tens of thousands of human genes that do not code for proteins, a phenomenon considered one of the key remaining mysteries of the human genome.
Researchers from UC San Francisco and the Broad Institute of MIT and Harvard have developed a new method for performing high-throughput functional screening of complex genetic interactions.
The U.S. Food and Drug Administration has awarded the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) a five-year grant with up to $25 million in funding.
The National Science Foundation has awarded $24 million over five years for a new ‘blue-sky’ bioengineering center based at UCSF.
Using advanced imaging technology that allowed them to spy on interactions among cells in the lymph nodes of living mice, a research team led by UCSF scientists has identified a cell that is a key player in mounting the immune system’s defense against cancer.
Ten years after the QB3 Garage incubator launched, the idea has grown an innovation ecosystem and become the catalyst for state legislation that could help turn ideas at UC campuses into job-providing companies.
UCSF is starting a campus-wide bioethics program led by the noted bioethics scholar Barbara Koenig to ensure that the rapid advances in biomedical technology are incorporated ethically into research and medicine.
A team of researchers at UCSF has devised a new approach for early stage drug discovery that uses techniques from the world of computer vision in combination with a powerful new tool.
If depression is caused by flawed brain circuitry, it may be possible to shift that circuitry toward healthy neural processing instead. UCSF researchers hope to map and correct aberrant neural behavior to cure mood disorders.
A UCSF-led team has developed a technique to build tiny models of human tissues, called organoids, more precisely than ever before using a process that turns human cells into a biological equivalent of LEGO bricks.
Keith Yamamoto, PhD, vice chancellor for research at UC San Francisco, has been named to a national advisory group to guide research and clinical decisions about the use of genome editing technologies to treat human disease.
